Epsilon Healthcare Ltd (EPN) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.265x

Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has a cash flow conversion efficiency ratio of 0.265x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.03 Million ≈ $728.19K USD) by net assets (AU$3.88 Million ≈ $2.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Epsilon Healthcare Ltd worth for the company's overall valuation and market capitalisation.

Epsilon Healthcare Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Epsilon Healthcare Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Epsilon Healthcare Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Epsilon Healthcare Ltd ranked by their cash flow conversion efficiency. Explore EPN cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ECP Emerging Growth Ltd AU:ECP	-0.023x
Curanex Pharmaceuticals Inc Common Stock NASDAQ:CURX	-0.643x
HEBEI YICHEN GRP H YC 05 F:HE2	N/A
Idealist Gayrimenkul Yatirim Ortakligi AS IS:IDGYO	-0.393x
ARB IOT Group Limited Ordinary Shares NASDAQ:ARBB	0.055x
Jcurve Solutions Ltd AU:JCS	0.778x
Gaxos.ai Inc NASDAQ:GXAI	-0.067x
SynBiotic SE F:SBX	N/A

Annual Cash Flow Conversion Efficiency for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Epsilon Healthcare Ltd from 2016 to 2025. View EPN stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$1.91 Million ≈ $1.35 Million	AU$-3.13 Million ≈ $-2.21 Million	-1.635x	-413.48%
2024-12-31	AU$10.70 Million ≈ $7.57 Million	AU$-3.41 Million ≈ $-2.41 Million	-0.318x	-241.31%
2023-12-31	AU$7.54 Million ≈ $5.33 Million	AU$-703.37K ≈ $-497.68K	-0.093x	+66.36%
2022-12-31	AU$9.27 Million ≈ $6.56 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.277x	+0.04%
2021-12-31	AU$19.57 Million ≈ $13.85 Million	AU$-5.43 Million ≈ $-3.84 Million	-0.277x	+19.21%
2020-12-31	AU$25.32 Million ≈ $17.91 Million	AU$-8.69 Million ≈ $-6.15 Million	-0.343x	+2.43%
2019-12-31	AU$22.32 Million ≈ $15.79 Million	AU$-7.86 Million ≈ $-5.56 Million	-0.352x	-68.97%
2018-12-31	AU$28.09 Million ≈ $19.87 Million	AU$-5.85 Million ≈ $-4.14 Million	-0.208x	-136.88%
2017-12-31	AU$21.36 Million ≈ $15.11 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.088x	-574.77%
2016-12-31	AU$11.34 Million ≈ $8.03 Million	AU$-147.81K ≈ $-104.58K	-0.013x	--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$7.98 Million

AU$11.28 Million AUD

Market Cap Rank

#27700 Global

#1367 in Australia

Share Price

AU$0.03

Change (1 day)

+3.57%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$1.08